Neil Mhaskar

Neil has over 30 years of experience in pharmaceutical development, CMC strategy, global technical operations, supply chain management, CMC regulatory affairs, and compliance from precandidate nomination through Phase 1 – Phase 3 clinical development to market launch and lifecycle management. Recently, Neil was VP of CMC at ORIC Pharmaceuticals and Prana Biotechnology where he led critical development, strategic planning, and technical operations for drug substances, drug products, and CTMs in support of global clinical trials. Neil also served in senior CMC management roles with Takeda/Millennium, Sanofi Genzyme, and Gilead Sciences where he made significant contributions to the development pipeline and marketed products such as Mozobil®, Zydelig®, Campath®, and Remdesivir®. Neil received his Ph.D. in Chemistry from M.S. University, India, and completed his postdoctoral research at Rice University, Wiess School of Natural Sciences.